Promising Advances in Treating Renal Medullary Carcinoma
Unlike other types of kidney cancer, RMC poses a significant challenge with less than 5 percent of patients surviving beyond three years using standard treatments. However, recent research offers new hope.
Kidney Cancer and COVID-19
What should kidney cancer patients know about COVID-19 and vaccines? Watch as Dr. Pavlos Msaouel shares information.
If You Suspect Kidney Cancer, What Should You Do?
What should you do if you suspect kidney cancer? Watch as Dr. Pavlos Msaouel shares kidney cancer symptoms that you should discuss with your doctor.
Advanced Renal Cell Carcinoma and Pembrolizumab and Lenvatinib Approvals
What do the advanced renal cell carcinoma approvals of pembrolizumab and levatinib mean for patients? Watch as Dr. Pavlos Msaouel shares an update.
What Are Common Therapy Options for Kidney Cancer?
Dr. Pavlos Msaouel provides an overview of common therapies, types of kidney cancer they are used in, and how the treatments work against kidney cancer.
What Role Does Screening Play in Kidney Cancer Prevention?
How is kidney cancer screening utilized in prevention? Watch as Dr. Pavlos Msaouel explains.
Is There a Connection Between Kidney Cancer and Exercise?
Dr. Pavlos Msaouel explains the benefits of exercise in kidney cancer prevention and the advice about exercise levels that are recommended for those with sickle cell trait.
What Specialists Treat Kidney Cancer?
Dr. Pavlos Msaouel explains specialists who are qualified in kidney cancer treatments and the type of specialist assigned according to the patient's stage.
Is Kidney Cancer More Prevalent In Certain Populations?
Dr. Pavlos Msaouel explains the prevalence of kidney cancer, how detection has changed, and populations that have shown higher kidney cancer incidence.
What Notable Disparities Are Seen in Kidney Cancer Treatment?
Dr. Pavlos Msaouel shares population groups and lifestyle and environmental factors that show increased risk of kidney cancer and how to improve awareness.
Does Kidney Cancer Favor a Specific Kidney?
Dr. Pavlos Msaouel explains the occurrence of the kidney cancer subtype of renal medullary carcinoma and the specific population in which RMC is most frequently diagnosed.
What Lab Tests Are Associated With Kidney Function?
Dr. Pavlos Msaouel shares how kidney function is measured and the impact that bad kidney function may have on the risk of kidney cancer development.
Is There a Hereditary Concern With Kidney Cancer?
Dr. Pavlos Msaouel explains baseline kidney cancer risk, how much risk increases in relatives, and when it makes sense to have genetic evaluation for proactive screening.
What Known Risk Factors Are Seen in Kidney Cancer?
Dr. Pavlos Msaouel shares an overview of genetic and environmental factors that can put people at higher kidney cancer risk.
What Are the Stages and Types of Kidney Cancer?
Dr. Pavlos Msaouel shares insight about various types of kidney cancer and what occurs during the different stages of kidney cancer.
How Is Kidney Cancer Diagnosed?
Dr. Pavlos Msaouel explains symptoms that can develop and imaging and other tests that providers examine in diagnosis.
Heart Behind the White Coat | RMC Expert Dr. Pavlos Msaouel
Renal medullary carcinoma and kidney cancer expert Dr. Pavlos Msaouel shares what inspired him to switch from laboratory research to clinical practice in this Heart Behind the White Coat (HBWC) program.
High-Intensity Exercise and Renal Medullary Carcinoma in Those With Sickle Cell Trait
As the most commonly occurring blood disorder in the world, sickle cell trait primarily impacts those in the BIPOC community with African ancestry. We connected with Dr. Pavlos Msaouel about a study on high-intensity exercise in those with sickle cell trait.
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
The molecular profile of RMC distinguishes it from other renal malignancies
RMC harbors a high number of focal chromosomal alterations
RMC has a distinct immune profile characterized by upregulation of cGAS-STING
DNA replication stress is a hallmark of RMC that can be therapeutically targeted
Renal Medullary Carcinoma and COVID-19 - Protecting Patients With Advanced Cancers
Dr. Pavlos Msaouel speaks on the relationship between advanced or aggressive cancers, such as renal medullary carcinoma (RMC) and the novel coronavirus, COVID-19.